The company, also known as DRW, shared early data on its forthcoming multiplex qPCR-based platform and infectious disease ...

The agency could continue to pursue more extensive LDT oversight by tightening control over items like RUO reagents and specimen collection devices.

The PD-L1 IHC 22C3 PharmDx (Code SK006) assay is now certified for use to aid treatment decisions for patients with gastric or gastroesophageal junction adenocarcinoma.

VIENNA – Irish researchers presented data Saturday at the European Society of Clinical Microbiology and Infectious Diseases ...

The blood test detects a protein biomarker to aid in the diagnosis of axial spondyloarthritis, which is often mistaken for lower back pain.

The firm is developing a kitted version of the four-biomarker combination test, and it plans to commercialize them in the EU and US markets.

NEW YORK – The US Food and Drug Administration last month granted 510(k) marketing clearances for a combination clinical chemistry and immunoassay instrument, a blood clot drug companion diagnostic ...

NEW YORK — Abbott on Wednesday announced that its Q1 2025 Diagnostics revenues declined 7 percent year over year, while its total revenues grew 4 percent. For the three months ended March 31, Abbott ...

In a session at the conference, multiple researchers presented data on their implementation of metagenomic sequencing for diagnostic use cases.